News

Olivia Williams opened up about her harrowing journey with pancreatic cancer, revealing she experienced years of misdiagnoses, dismissals by doctors.
A Tulsa woman now gets her cancer treatments five minutes from home, instead of in Oklahoma City, because of the OU Health Stephenson Cancer Center's new partnership with Hillcrest.
A common pinworm medication may stop and reverse cancer growth in Merkel cell carcinoma, an aggressive form of skin cancer, ...
The FDA has approved Cabometyx (cabozantinib) for previously treated, unresectable, locally advanced or metastatic, well-differentiated neuroendocrine tumors.
Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, today announced ...
The FDA has approved Cabometyx for some patients 12 years old and older with previously treated neuroendocrine tumors.
A phase 1 clinical trial is now open for enrollment to patients with high-grade neuroendocrine tumors to receive treatment ...
Checkpoint inhibitors have broadened treatment options for a growing list of tumor types, from melanoma to lung cancer. Very few high-grade neuroendocrine carcinomas respond to the drugs. But when ...
The researcher aims to investigate Bucillamine’s potential as a cancer treatment, particularly for boosting anti-tumor effects in patients with advanced solid tumors. This evaluation of Bucillamine in ...
Jennifer Chan, MD, MPH, discussed outcomes of treating neuroendocrine tumors (NETs) with cabozantinib depending on whether they were pancreatic NETs or extrapancreatic NETs. Jennifer Chan, MD, MPH, ...